Earnings NewsHealthcareChemoCentryx beats by $0.03.Mar. 13, 2014 5:14 PM ETAmgen Inc. (AMGN) StockBy: SA News Team ChemoCentryx (NASDAQ:CCXI): Q4 EPS of -$0.22 beats by $0.03. Revenue of $725K Press Release Recommended For YouMore Trending NewsSee More »About AMGN StockSymbolLast Price% Chg1D5D1M6M1Y5Y10YMarket CapPEYield (TTM)Rev Growth (YoY)Prev. CloseCompare to PeersRelated StocksSymbolLast Price% ChgAMGN--Amgen Inc.Trending AnalysisTrending News